BREAKING NEWS: FDA approves XDEMVY for treatment of Demodex blepharitis
by: David Hutton According to Tarsus Pharmaceuticals, lotilaner ophthalmic solution 0.25% (XDEMVY) is the first approved therapeutic for Demodex blepharitis and has demonstrated efficacy across multiple clinical measures of the…